Biohacking News cover art

Biohacking News

Biohacking News

By: Inception Point Ai
Listen for free

Summary

 Biohacking News Tracker: Stay Ahead in the World of Biohacking

Welcome to "Biohacking News Tracker," your go-to podcast for the latest updates and breakthroughs in the world of biohacking. From cutting-edge technologies and genetic engineering to personalized health and wellness strategies, we cover it all. Each episode features expert interviews, in-depth analysis, and the most current news in biohacking and human optimization.

Join us as we explore the intersection of biology and technology, uncovering innovative ways to enhance human potential. Whether you're a biohacking enthusiast, a tech aficionado, or simply curious about the future of health, "Biohacking News Tracker" offers insightful and actionable information. Subscribe now and stay ahead in the rapidly evolving world of biohacking.

For more info https://www.quietperiodplease.com/

This show includes AI-generated content.Copyright 2025 Inception Point Ai Politics & Government
Episodes
  • Biohacking Market Under Fire: Supplement Purity Crisis and Psychedelic Breakthroughs

    Biohacking Market Under Fire: Supplement Purity Crisis and Psychedelic Breakthroughs
    Apr 30 2026
    In the past 48 hours, the biohacking industry shows signs of strain amid a global supplement transparency crisis, with limited major deals or launches but rising scrutiny on product purity. Momentous Vital Aminos, endorsed by podcaster Andrew Huberman, continues gaining traction in emerging markets like India and the Netherlands, yet faces questions over a 2026 purity gap compared to European alternatives, potentially posing health risks for Dutch consumers due to inconsistent labeling and sourcing[1]. No verified new partnerships or product launches emerged in this window, though the broader sector grapples with supply chain opacity.

    Regulatory shifts hint at acceleration: a recent U.S. presidential executive order under Trump aims to fast-track psychedelic-based medical treatments, shifting biohacking's fringe energy from beatnik eras to mainstream policy, which could boost nootropics and therapeutic compounds[2]. No specific statistics from the past week surfaced, but the supplement market's transparency issues echo ongoing FDA warnings on unverified claims, with no reported price changes or consumer behavior pivots like surged Ozempic demand in adjacent wellness spaces.

    Emerging competitors in Europe emphasize stricter purity testing, challenging U.S. leaders like Momentous. Industry frontrunners respond by doubling down on influencer marketing—Huberman's series promotes Vital Aminos as a biohacking staple—while psychedelic firms eye FDA expedited pathways. Compared to last week's quieter reporting, current buzz centers on regulatory green lights versus purity scandals, signaling a maturing yet disrupted market. No major supply chain breaks or consumer shifts noted, keeping growth cautious at under 5 percent quarterly per prior estimates. Biohacking leaders like Momentous prioritize transparency audits to counter risks.

    (Word count: 248)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Show More Show Less
    2 mins
  • AI-Powered Fertility Biohacking: How South Korea's Femtech Is Reshaping Couples' Health

    AI-Powered Fertility Biohacking: How South Korea's Femtech Is Reshaping Couples' Health
    Apr 29 2026
    In the past 48 hours, the biohacking industry shows steady momentum with niche advancements in wellness tech, though no major market disruptions or verified statistics from the last week emerged. A standout development is a new 20-week sleep study launched April 27 from Dave Asprey's Beyond Biohacking Conference, challenging performance assumptions by tracking attendees' sleep optimization[1]. This highlights biohacking leaders like Asprey responding to consumer demands for evidence-based upgrades in recovery protocols.

    Emerging from South Korean femtech, which overlaps biohacking via AI-driven hormone tracking and fertility biohacks, Signaling's Soonr app launched recently as a couples-focused AI system integrating female cycles, sperm motility, BMI, sleep, and cortisol into a unified Fertility Score. It boasts 750,000 users and 61 percent week-one retention, far exceeding health app averages, positioning it as a biohacking tool for preconception[2]. Vespexx partners with Sugentech on FDA and EU-approved multihormone analyzers, building data moats for scalable fertility biohacks, while Noul's miLab CER device, debuted at CES 2026, delivers 93.9 percent sensitive cervical screening in 20 minutes, deployed in 28 countries with 410,000 diagnoses[2].

    The South Korean femtech market, valued at 478.5 million dollars in 2024 with 16.9 percent CAGR, benefits from a February 2026 MOU between women entrepreneurs and venture capital for global scaling, plus government funding up to 54,000 dollars per firm[2]. This institutional push addresses aging populations and wellness trends, with no reported price changes or supply issues, though US tariffs on wearables spur local manufacturing.

    Compared to prior weeks, activity remains subdued without blockbuster deals, but femtech's export playbook mirrors K-beauty's success, signaling biohacking's shift toward AI-personalized, couple-centric tools amid rising digital health adoption. Leaders emphasize clinic-home data bridges to counter infertility's 40 percent male-factor burden[2]. Overall, the sector advances incrementally, prioritizing retention and regulation over volatility.

    (Word count: 298)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Show More Show Less
    3 mins
  • Biohacking Industry Crisis: Credibility Collapse and the Future of Longevity Science

    Biohacking Industry Crisis: Credibility Collapse and the Future of Longevity Science
    Apr 28 2026
    In the past 48 hours, the biohacking industry is grappling with a severe credibility crisis sparked by revelations of Peter Attia's ties to Jeffrey Epstein, as detailed in a YouTube video by James Welsh on April 26, 2026, which has amassed over 5,600 views.[1] Attia, once a pillar of the longevity movement through his podcast The Drive, book Outlive, and advocacy for healthspan, fasting, VO2 max, and supplements, resigned from CBS on February 23, 2026, amid scandal, intensifying doubts about the sectors blend of science and hype.[1]

    No new product launches, deals, partnerships, or regulatory changes have surfaced in this period, signaling a stall in momentum.[1] Verified statistics from the past week remain absent for market movements, price shifts, supply chain issues, or consumer behavior changes, though online scrutiny of influencers has surged.[1] Chinese peptide imports, a biohacking staple, nearly doubled to about 328 million dollars in the first nine months of an unspecified recent year, hinting at supply growth but raising quality concerns.[4]

    This echoes 2023 controversies, like Attias Oura Ring lawsuit over stock options and study influence, underscoring recurring corruption fears over innovation.[1] Biotech giants such as Calico Life Sciences and Unity Biotechnology, funded by billions from Peter Thiel and Jeff Bezos since the 2010s, face eroding trust in unproven therapies like plasma transfusions and epigenetic tests.[1] Industry leaders have stayed silent on responses, potentially forcing a pivot from hype to evidence-based practices.[1]

    A separate 20-week sleep study tied to Dave Aspreys Beyond Biohacking Conference challenges performance assumptions, while Evolutamente promotes light-based health gains among biohackers.[3][5] Overall, the sector confronts trust erosion without fresh catalysts, contrasting any prior innovation buzz with current introspection.(298 words)

    For great deals today, check out https://amzn.to/44ci4hQ

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Show More Show Less
    2 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.